{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T08:12:39Z","timestamp":1793434359186,"version":"4.5.0"},"reference-count":29,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2012,10,30]],"date-time":"2012-10-30T00:00:00Z","timestamp":1351555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intl Journal of Cancer"],"published-print":{"date-parts":[[2013,5,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Long\u2010term population\u2010based survival data detailed by cancer subtype are important to measure the overall outcomes of malignancy managements. We provide net survival estimates at 1, 3, 5 and 10\u2010year postdiagnosis on 37,549 hematological malignancy (HM) patients whose ages were &gt;15 years, diagnosed between 1989 and 2004 and actively followed until 2008 by French population\u2010based cancer registries. These are, to our knowledge, the first unbiased estimates of 10\u2010year net survival in HMs detailed by subtypes. HMs were classified according to the International Classification of Diseases\u2010Oncology 3. Net survival was estimated with the unbiased Pohar\u2010Perme method. The results are reported by sex and age classes. The changes of these indicators by periods of diagnosis were tabulated and the trends of the net mortality rates over time since diagnosis graphed. In all, 5\u2010 and 10\u2010year age\u2010standardized net survivals after HMs varied widely from 81 and 76% for classical Hodgkin lymphoma (CHL) to 18 and 14% for acute myeloid leukemia (AML). Even in HMs with the most favorable prognoses, the net survival decreased between 5\u2010 and 10\u2010year postdiagnosis. Women had better prognoses than men and age at diagnosis was an unfavorable prognostic factor for most HMs. In patients &lt;55 years old, the net mortality rate decreased to null values 5\u2010year postdiagnosis in AML and 10\u2010year postdiagnosis in CHL, precursor non\u2010HL, chronic myelogenous leukemia, diffuse large B\u2010cell lymphoma and follicular lymphoma. The prognoses improved for various HMs over the study period. The obtained unbiased indicators are important to evaluate national cancer plans.<\/jats:p>","DOI":"10.1002\/ijc.27889","type":"journal-article","created":{"date-parts":[[2012,10,3]],"date-time":"2012-10-03T12:59:26Z","timestamp":1349269166000},"page":"2378-2387","source":"Crossref","is-referenced-by-count":71,"title":["Unbiased estimates of long\u2010term net survival of hematological malignancy patients detailed by major subtypes in France"],"prefix":"10.1002","volume":"132","author":[{"given":"Alain","family":"Monnereau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Troussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Belot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne\u2010Val\u00e9rie","family":"Guizard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne\u2010Sophie","family":"Woronoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Lap\u00f4tre\u2010Ledoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Iwaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Tretarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Maynadi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"The French Network of Cancer Registries (FRANCIM)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,10,30]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.25516"},{"key":"e_1_2_7_3_2","unstructured":"HowladerN NooneAM KrapchoM et al. SEER cancer statistics review 1975\u20102008 National Cancer Institute. Bethesda MD.http:\/\/seer.cancer.gov\/csr\/1975_2008\/ based on November 2010 SEER data submission posted to the SEER web site 2011."},{"key":"e_1_2_7_4_2","unstructured":"INVS. Projection de l'incidence et de la mortalit\u00e9 par cancer en France en 2011. Rapport technique. Saint\u2010Maurice: Institut de veille sanitaire;2011. 78p.http:\/\/www.invs.sante.fr.2011."},{"key":"e_1_2_7_5_2","first-page":"337","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Swerdlow SH","year":"2008"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-06-289561"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2007.12.016"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.11.029"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.034264"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.3109\/02841861003631495"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.26315"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21995"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.07.021"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1541-0420.2011.01640.x"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4464"},{"key":"e_1_2_7_16_2","first-page":"357","volume-title":"International classification of diseases for oncology","author":"Fritz A","year":"2000"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-11-051672"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2004.07.002"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-03-0250"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(07)70246-2"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022457"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.0779"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.34.7146"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djr418"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2011.03.012"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(06)69780-8"},{"key":"e_1_2_7_28_2","first-page":"CD007941","article-title":"Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma","volume":"8","author":"Bauer K","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_29_2","first-page":"CD007110","article-title":"Chemotherapy alone versus chemotherapy plus radiotherapy for early stage Hodgkin lymphoma","volume":"2","author":"Herbst C","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1104576"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.27889","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ijc.27889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T03:40:32Z","timestamp":1697514032000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.27889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,30]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,5,15]]}},"alternative-id":["10.1002\/ijc.27889"],"URL":"https:\/\/doi.org\/10.1002\/ijc.27889","archive":["Portico"],"relation":{},"ISSN":["0020-7136","1097-0215"],"issn-type":[{"value":"0020-7136","type":"print"},{"value":"1097-0215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,30]]}}}